Updated COVID-19 infection control recommendations issued by the Centers for Disease Control and Prevention can help reduce risk to medical facilities and its healthcare personnel.
New recommendations issued by the American Gastroenterological Association offer clinical practice guidelines for treating inflammatory bowel disease patients during the COVID-19 emergency.
New Research Highlights Concerns Related to Use of Chloroquine, Hydroxychloroquine and Azithromycin for Treating COVID-19 Patients
New research indicates there is weak evidence that chloroquine, hydroxychloroquine and azithromycin can effectively treat and prevent COVID-19 and the drugs carry potentially serious risks.
New York Public Health Law Provides Immunity for Facilities and Professionals Responding to COVID-19
New York has enacted the Emergency Disaster Treatment Protection Act, a new statute in the Public Health Law that provides healthcare facilities and professionals immunity from civil or criminal liability when delivering care related to COVID-19.